The number of polydrug users is increasing and it has been reported that 92% of those taking heroin are also using cocaine. Randox Toxicology’s DoA ULTRA panel detects up to 20 targeted drugs from a single sample and offers the largest cross-reactivity profile of over 240 analytes.
With excellent assay precision and performance, our biochip array technologyeliminates false reporting and reduces unnecessary confirmatory tests. Our biochip arrays offer CVs typically less than 10%, producing an accurate drug profile to ensure confidence in results.
Designed to work across a wide variety of matrices, this revolutionary multi-analyte testing platform allows toxicologists to achieve a complete immunoassay profile in the initial screening phase.
Urine - Whole Blood - Oral Fluid